Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ today. Relationships with industry are common among investigators of randomised clinical trials (RCTs) – raising concerns about the effect that financial ties may have on the evidence …